Quadrant Capital Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-160
| Closed | -$676 | – | 2776 |
|
|
2023
Q4 | $676 | Buy |
160
+43
| +37% | +$182 | ﹤0.01% | 2593 |
|
|
2023
Q3 | $506 | Sell |
117
-4,874
| -98% | -$21.1K | ﹤0.01% | 2567 |
|
|
2023
Q2 | $32.9K | Buy |
4,991
+4,612
| +1,217% | +$30.4K | ﹤0.01% | 1464 |
|
|
2023
Q1 | $2.57K | Sell |
379
-134
| -26% | -$910 | ﹤0.01% | 2381 |
|
|
2022
Q4 | $3.79K | Sell |
513
-1,356
| -73% | -$10K | ﹤0.01% | 2271 |
|
|
2022
Q3 | $18K | Buy |
1,869
+1,853
| +11,581% | +$17.8K | ﹤0.01% | 1619 |
|
|
2022
Q2 | $0 | Hold |
16
| – | – | ﹤0.01% | 2756 |
|
|
2022
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 2708 |
|
|
2021
Q4 | $0 | Sell |
16
-32
| -67% | – | ﹤0.01% | 2709 |
|
|
2021
Q3 | $1K | Buy |
48
+8
| +20% | +$167 | ﹤0.01% | 2404 |
|
|
2021
Q2 | $1K | Buy |
40
+24
| +150% | +$600 | ﹤0.01% | 2339 |
|
|
2021
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 2464 |
|
|
2020
Q4 | $0 | Buy |
+16
| New | – | ﹤0.01% | 2380 |
|
|
2020
Q3 | – | Sell |
-45
| Closed | -$1K | – | 2317 |
|
|
2020
Q2 | $1K | Buy |
+45
| New | +$1K | ﹤0.01% | 2149 |
|